MNG Laboratories a portfolio company of HealthEdge has been sold to LabCorp
Client: Healthedge Investment Partners
Client Location: U.S.
Target: MNG Laboritories
Target Location: U.S.
Buyer: Laboratory Corporation of America
Buyer Location: U.S.
Target Description: MNG is a leading clinical diagnostic provider specializing in neurogenetic and complex biochemical testing.
Meet our Senior Team
View More Transactions in Healthcare
Lincoln International advised Proclinic Group, a portfolio company of Miura Partners, on the acquisition of Meditrans
Lincoln International advised Frazier Lifesciences Acquisition Corporation on merger with NewAmsterdam Pharma Holding
Lincoln International advised Pfingsten Partners on the sale of Full Spectrum Group to CBRE Group
Lincoln International advised Rarebreed, a portfolio company of Trilantic Capital Partners and Halle Capital Management, on receiving significant investment from Revelstoke Capital Partners
Lincoln International advised Corus a portfolio company of Careventures and Quadrum Capital on the refinancing and acquisition of Nordentic
Any information or testimonials contained in this post may not be representative of the experience of other clients and is no guarantee of future performance or success.